tiprankstipranks
Zura Bio to Present at Healthcare Conference
Company Announcements

Zura Bio to Present at Healthcare Conference

Don't Miss our Black Friday Offers:

An announcement from Zura Bio ( (ZURA) ) is now available.

Zura Bio Limited, a clinical-stage immunology company, is set to present at the Piper Sandler 36th Annual Healthcare Conference, showcasing their innovative dual-pathway antibodies for autoimmune and inflammatory diseases. The company is focusing on developing therapeutic indications for three assets, aiming to prove their efficacy and safety in diseases like systemic sclerosis. Investors can catch a live webcast of the event, with a replay available on their website.

See more data about ZURA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskZura Bio Announces Phase 2 Tibulizumab Study
TheFlyZura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App